np event 2254995 0E193A 1
Nov 6, 2025
- Nov 5, 2026
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
1.0

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

np document 888746 0E193A 5
Cardiology
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Th...
Group 39553
Cardiometabolic
Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Th...
np document 888746 0E193A 5
Pulmonology
Update on Long-Acting Nebulizers for Guideline-Based Maintenance Treatments for Patients w...